|
| Pharmakon Biotec Philippines: To Sack or to Save |
| 作者姓名：Sandeep Puri, Bindu Gupta, Rakesh Singh |
| 商品類型：Case (Field) | 商品編號：W40080 |
| 出版日期：2024/12/13 | 內容長度：4 頁 |
In 2024, the managing director of a pharma company faced an ethical dilemma after being informed that a senior manager had falsified her resume and manipulated the reference check process when she applied for her position three and a half years before. After first denying all allegations, the senior manager eventually confessed. However, her pregnancy may have complicated the situation for the company. Given that the company had planned to promote .....more
|
| Pharmakon Biotec Philippines: To Sack or To Save - Teaching Note |
| 作者姓名：Sandeep Puri, Bindu Gupta, Rakesh Singh |
| | 商品編號：W40081 |
| 出版日期：2024/12/13 | 內容長度：12 頁 |
Teaching note for product W40080.
|
| Reliance and Disney: Reshaping the Media and Entertainment Business in India |
| 作者姓名：Siddhant Puri, Sandeep Puri, Darren Meister, Shaphali Gupta, Rakesh Singh |
| 商品類型：Case (Pub Mat) | 商品編號：W38350 |
| 出版日期：2024/07/23 | 內容長度：10 頁 |
In May 2024, the National Company Law Tribunal of India approved the merger of Star India Private Limited (Star India) and Viacom18 Media Private Limited (Viacom18). Star India was a broadcasting service owned by The Walt Disney Company and Viacom18 was a media company owned by Reliance Industries Limited. The two companies had been working on an agreement to merge the two media and entertainment businesses since December 2023. A new subsidiary of .....more
|
| Reliance and Disney: Reshaping the Media and Entertainment Business in India - Teaching Note |
| 作者姓名：Siddhant Puri, Sandeep Puri, Darren Meister, Shaphali Gupta, Rakesh Singh |
| 商品類型： | 商品編號：W38351 |
| 出版日期：2024/07/23 | 內容長度：13 頁 |
Teaching note for product W38350.
|
| Maha Research Labs: Sales Force Effectiveness |
| 作者姓名：Sandeep Puri, Rakesh Singh, Bindu Gupta, Shraddha Puri |
| 商品類型：Case (Field) | 商品編號：W27721 |
| 出版日期：2022/07/22 | 內容長度：10 頁 |
In January 2022, Maha Research Labs Private Limited (MRL) needed to boost its sales force effectiveness (SFE). Due to the COVID-19 pandemic, MRL experienced losses in sales revenue and saw dwindling profits through 2020 and 2021. The pandemic had changed the sales ecosystem of the pharmaceutical industry, with many physicians and retailers now preferring online sales presentations. MRL’s managing director was concerned about the increased marketing .....more
|
| Maha Research Labs: Sales Force Effectiveness - Teaching Note |
| 作者姓名：Sandeep Puri, Rakesh Singh, Bindu Gupta, Shraddha Puri |
| | 商品編號：W27722 |
| 出版日期：2022/07/22 | 內容長度：10 頁 |
Teaching note for product W27721.
|
| Laurs & Bridz: Sales Targets and Antiviral Drug Launch |
| 作者姓名：Sandeep Puri, Rakesh Singh, Jatin Batra |
| 商品類型：Case (Field) | 商品編號：W25457 |
| 出版日期：2021/11/19 | 內容長度：9 頁 |
In October 2020, the managing director of Laurs & Bridz Pharmaceuticals Private Limited was considering changing the company’s sales strategy to reflect the challenges that India’s pharmaceutical industry was facing during the COVID-19 pandemic. The company was also considering launching a new antiviral drug. The COVID-19 pandemic had disrupted many routine sales practices, such as in-person meetings with customers, and had also affected drug .....more
|
| Laurs & Bridz: Sales Targets and Antiviral Drug Launch - Teaching Note |
| 作者姓名：Sandeep Puri, Rakesh Singh, Jatin Batra |
| 商品類型： | 商品編號：W25458 |
| 出版日期：2021/11/19 | 內容長度：9 頁 |
Teaching note for product W25457.
|
| Sarva Pharmaceuticals In Cambodia: Fight or Fold? - Teaching Note |
| 作者姓名：Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu Gupta |
| 商品類型： | 商品編號：8B20A060 |
| 出版日期：2020/08/07 | 內容長度：12 頁 |
Teaching note for product 9B20A060.
|
| Sarva Pharmaceuticals In Cambodia: Fight or Fold? |
| 作者姓名：Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu Gupta |
| 商品類型：Case (Field) | 商品編號：9B20A060 |
| 出版日期：2020/08/07 | 內容長度：10 頁 |
In January 2020, Jai Prakash Chaubey, the managing director of Sarva Pharmaceuticals Private Limited (Sarva), needed to decide whether or not to accept a proposal from Gursim Pharmaceutical Limited (Gursim) to market some of Sarva’s products in Cambodia. Sarva had been performing well; however, the company’s profitability in Cambodia was minimal. Should Chaubey accept Gursim’s offer? Or should he hire a new country head who could drive the sales in .....more
|
|